These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18268491)

  • 1. Cortactin expression predicts poor survival in laryngeal carcinoma.
    Gibcus JH; Mastik MF; Menkema L; de Bock GH; Kluin PM; Schuuring E; van der Wal JE
    Br J Cancer; 2008 Mar; 98(5):950-5. PubMed ID: 18268491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
    Gibcus JH; Menkema L; Mastik MF; Hermsen MA; de Bock GH; van Velthuysen ML; Takes RP; Kok K; Alvarez Marcos CA; van der Laan BF; van den Brekel MW; Langendijk JA; Kluin PM; van der Wal JE; Schuuring E
    Clin Cancer Res; 2007 Nov; 13(21):6257-66. PubMed ID: 17975136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
    Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
    Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.
    Schrijvers ML; Pattje WJ; Slagter-Menkema L; Mastik MF; Gibcus JH; Langendijk JA; van der Wal JE; van der Laan BF; Schuuring E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1220-6. PubMed ID: 22208968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
    Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
    Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
    Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
    Gibcus JH; Kok K; Menkema L; Hermsen MA; Mastik M; Kluin PM; van der Wal JE; Schuuring E
    Hum Genet; 2007 Apr; 121(2):187-201. PubMed ID: 17171571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
    Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
    PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
    Fracchiolla NS; Pruneri G; Pignataro L; Carboni N; Capaccio P; Boletini A; Buffa R; Neri A
    Cancer; 1997 Mar; 79(6):1114-21. PubMed ID: 9070488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
    Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
    Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.